ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.
McLaughlin
Vallerie V
VV
Archer
Stephen L
SL
Badesch
David B
DB
Barst
Robyn J
RJ
Farber
Harrison W
HW
Lindner
Jonathan R
JR
Mathier
Michael A
MA
McGoon
Michael D
MD
Park
Myung H
MH
Rosenson
Robert S
RS
Rubin
Lewis J
LJ
Tapson
Victor F
VF
Varga
John
J
D000465:Algorithms; D000572:American Heart Association; D000959:Antihypertensive Agents / Q000627:therapeutic use; D006328:Cardiac Catheterization; D065128:Endothelin Receptor Antagonists; D011464:Epoprostenol / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D008403:Mass Screening; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D012955:Societies, Medical; D014481:United States
D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D010726:Phosphodiesterase Inhibitors; D011464:Epoprostenol